Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -101.07% is 39% below its 5-year average of -72.49%, near the high end of its 5-year range (-903.55%–42.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.56% below its 12-month average of -78.01%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -101.07%.
RETURN ON INVESTED CAPITAL (ROIC)
-101.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-78.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-82.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-72.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-68.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.56%
CURRENT VS 3Y AVG
-22.38%
CURRENT VS 5Y AVG
-39.42%
CURRENT VS 10Y AVG
-47.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-183.53%
vs the sector median at left
Exicure, Inc.
Market Cap
$6.88M
Return on Invested Capital (ROIC)
-101.07%
TTM Avg
-78.01%
3Y Avg
-82.58%
5Y Avg
-72.49%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$7.04M
Return on Invested Capital (ROIC)
-232.05%
TTM Avg
-321.25%
3Y Avg
-211.94%
5Y Avg
-167.22%
Market Cap
$7.07M
Return on Invested Capital (ROIC)
-208.39%
TTM Avg
-54.78%
3Y Avg
-47.23%
5Y Avg
-47.23%
Market Cap
$7.12M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-166.69%
3Y Avg
-591.28%
5Y Avg
-439.14%
Market Cap
$7.15M
Return on Invested Capital (ROIC)
-211.58%
TTM Avg
-206.45%
3Y Avg
-187.44%
5Y Avg
-143.49%
Market Cap
$6.61M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$6.60M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$6.60M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | -101.07% | -78.01% | -82.58% | -72.49% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -90.17% | -79.44% | -64.42% | -71.54% |
| KALA BIO, Inc. (KALA)vs › | $7.04M | -232.05% | -321.25% | -211.94% | -167.22% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | -208.39% | -54.78% | -47.23% | -47.23% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | N/A | -166.69% | -591.28% | -439.14% |
| Longeveron Inc. (LGVN)vs › | $7.15M | -211.58% | -206.45% | -187.44% | -143.49% |
| Biomerica, Inc. (BMRA)vs › | $6.61M | -117.93% | -116.75% | -95.39% | -83.55% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | N/A | -251.59% | -2172.61% | -1769.42% |
| Aclarion, Inc. (ACON)vs › | $6.60M | -57.11% | -311.64% | -524.77% | -524.77% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | -107.99% | -407.39% | -445.97% | -342.27% |
ROIC
-101.1%
ROE
-847.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -101.07% |
| 2026-03-31 | -105.31% |
| 2025-12-31 | -40.73% |
| 2025-09-30 | -74.31% |
| 2025-06-30 | -68.61% |
| 2025-03-31 | -50.31% |
| 2024-12-31 | -102.06% |
| 2024-09-30 | -88.03% |
| 2024-06-30 | -83.40% |
| 2024-03-31 | -129.80% |
| 2023-12-31 | -165.34% |
| 2023-09-30 | 42.01% |
| 2023-06-30 | 17.98% |
| 2023-03-31 | 5.58% |
| 2022-12-31 | -8.24% |
| 2022-09-30 | -903.55% |
| 2022-06-30 | -299.15% |
| 2022-03-31 | -283.07% |
| 2021-12-31 | -166.03% |
| 2021-09-30 | -110.09% |
| 2021-06-30 | -77.12% |
| 2021-03-31 | -50.71% |
| 2020-12-31 | -29.33% |
| 2020-09-30 | -23.40% |
| 2020-06-30 | -24.36% |
| 2020-03-31 | -24.08% |
| 2019-12-31 | -29.86% |
| 2019-09-30 | -30.34% |
| 2019-06-30 | -125.13% |
| 2019-03-31 | -101.58% |
| 2018-12-31 | -81.68% |
| 2018-09-30 | -63.96% |
| 2018-06-30 | -95.85% |
| 2018-03-31 | -58.19% |
| 2017-12-31 | -39.27% |
| 2017-09-30 | -72.07% |
| 2017-06-30 | -485.78% |
| 2016-12-31 | -167.81% |
